AstraZeneca PLC is 2.0x more valuable than PFIZER INC by market capitalization ($286.27 B vs $146.15 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PFE | AZN |
|---|---|---|
| Market cap | $146.15 B | $286.27 B |
| US-listed rank | #105 | #45 |
| Revenue (latest FY) | $62.58B | - |
| Net income (latest FY) | $7.77B | - |
| Net margin | 12.4% | - |
| P/E (trailing FY) | 18.8 | - |
| SEC filings | 985 | 1,004 |
AstraZeneca PLC is 2.0x more valuable than PFIZER INC by market capitalization ($286.27 B vs $146.15 B).
Full pages: PFIZER INC and AstraZeneca PLC, or browse the full rankings.